OmniActive has been Upgraded to Crisil A with Positive Outlook

We are happy to announce that credit rating of OmniActive Health Technologies has been upgraded to  CRISIL A with positive outlook (from A- with stable outlook). CRISIL is an S&P Global Inc company, with its rating preferred by various financial institutions.

It confirms OmniActive’s established market position in the nutraceuticals segment as well as a solid financial profile. This is a reflection of the value that we have built over the years and now is a stepping stone towards a much stronger foundation for growth.